Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Organogenesis Holdings Inc.
ORGO ยท SEC Filings
website
854
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating,...
Price
0.9071
Market Cap
118.12 M
Float
83.14 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about ORGO
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Organogenesis Holdings Inc.
ORGO ยท SEC Filings
83.14 M
Float
0.9071
Price
118.12 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 7, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 7, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results and Updates Full Year Outlook
Nov 5, 2026
8-K
Organogenesis Holdings Inc. Enters Into $75 Million At-the-Market Sales Agreement
Aug 6, 2026
8-K
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
Aug 6, 2026
8-K
Organogenesis Holdings Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 16, 2026
8-K
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 7, 2026
8-K
Organogenesis Reports Record Q4 2025 Revenue and Strong Full-Year Results, Projects 2026 Revenue Decline Due to Market Adaptation
Feb 26, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
[No Baby Shelf]* August 2026 ATM | Offering amount: $75,000,000 | Bank: BTIG, LLC and Citizens JMP Securities, LLC
Aug 6, 2026
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
Dec 23, 2024
424B4
17,500,000 Shares
Nov 16, 2020
424B5
9,000,000 Shares
Nov 22, 2019
424B5
9,000,000 Shares
Nov 19, 2019
424B3
46,853,325 Shares of Classย A Common Stock
Feb 14, 2019
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 7, 2025
S-3
Form S-3 - Registration statement under Securities Act of 1933
Dec 19, 2024
D
Form D - Notice of Exempt Offering of Securities - Item 06b
Nov 27, 2024
S-3
SHELF | Offering amount: $250,000,000.00 EFFECTIVE
Aug 8, 2024
S-8
Registration
Dec 9, 2022
S-1/A
17,500,000 Shares
Nov 10, 2020
Proxies
TYPE
HEADLINE
FILED AT
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 30, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
May 12, 2025
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Apr 29, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 29, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
May 1, 2023
DEF 14A
Form DEF 14A - Other definitive proxy statements
May 10, 2022
Ownerships
TYPE
HEADLINE
FILED AT
4
Grow Brian (Reporting)
Apr 24, 2026
4
Leibowitz Arthur S (Reporting)
Mar 11, 2026
4
Driscoll Michael Joseph (Reporting)
Mar 11, 2026
4
Cavorsi Robert (Reporting)
Mar 3, 2026
4/A
Montecalvo Antonio S. (Reporting)
Mar 3, 2026
4/A
Gillheeney Gary S. (Reporting)
Mar 3, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Dec 23, 2024
CORRESP
Form CORRESP - Correspondence
Dec 20, 2024
LETTER
Form UPLOAD - SEC-generated letter
Dec 20, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Aug 16, 2024
CORRESP
Form CORRESP - Correspondence
Aug 13, 2024
LETTER
Form UPLOAD - SEC-generated letter
Aug 13, 2024